TREATMENT OF PROSTATE CANCER AND HEMATOLOGIC NEOPLASMS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 30, 2015
app pub date -
May 10, 2013
filing date -
Aug 16, 2012
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Prostate cancer and hematological neoplasms are treated by administration of (i) a compound of Formula I: wherein: R1 is —OH or —O—P(O)(OH)2; and R2 is (II) or (III); (ii) N6-benzyladenosine, (iii) N-(phenylmethyl)-7-β-D-ribofuranosyl-7H-pyrrolo [2,3 -d]pyrimidin-4-amine, (iv) N-(phenylmethyl)-7β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine 5′-monophosphate; or a pharmaceutically acceptable salt thereof.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully